ConductScience.org, home

Paper8527482

Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors.

Kun LE and 9 others. Hum Gene Ther, 1995. Cited by 43 papers, by iCite.

Cite this record

ConductScience Library. Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors. Papers, record 8527482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8527482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors.
PubMed
Journal
Hum Gene Ther
PubMed
Year
1995
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
1.05
iCite
Revised in PubMed
2013-11-21
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kun LEL E
2Gajjar AA
3Muhlbauer MM
4Heideman RLR L
5Sanford RR
6Brenner MM
7Walter AA
8Langston JJ
9Jenkins JJ
10Facchini SS

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GanciclovirMajor topic
Genes, ViralMajor topic
Genetic TherapyMajor topic
SimplexvirusMajor topic
Supratentorial NeoplasmsMajor topic
Thymidine KinaseMajor topic
Adolescent
Animals
Child
Child, Preschool
Clinical Protocols
Clinical Trials, Phase I as Topic
Genetic Vectors
Humans
Injections, Intralesional
Injections, Intravenous
Neoplasm Recurrence, Local
Retroviridae

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02957331Beta Blockade in in Traumatic Brain InjuryBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
19357954The evolution and application of techniques in molecular biology to human brain tumors: a 25 year perspective.J Neurooncol2009https://conductscience.org/library/papers/19357954PubMed
19003311Lysine: Is it worth more?Cytotechnology2001https://conductscience.org/library/papers/19003311PubMed
17625614Gene therapy trials for the treatment of high-grade gliomas.Gene Ther Mol Biol2007https://conductscience.org/library/papers/17625614PubMed
11571568AV.TK-mediated killing of subcutaneous tumors in situ results in effective immunization against established secondary intracranial tumor deposits.Gene Ther2001https://conductscience.org/library/papers/11571568PubMed
11376567Suicide gene therapy for chemically induced rat bladder tumor entailing instillation of adenoviral vectors.Jpn J Cancer Res2001https://conductscience.org/library/papers/11376567PubMed
10533726Selective transvascular delivery of oligodeoxynucleotides to experimental brain tumors.J Neurooncol1999https://conductscience.org/library/papers/10533726PubMed
10467366Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant.Gene Ther1999https://conductscience.org/library/papers/10467366PubMed
9811686
Differential intracellular compartmentalization of herpetic thymidine kinases (TKs) in TK gene-transfected tumor cells: molecular characterization of the nuclear localization signal of herpes simplex virus type 1 TK.
J Virol1998https://conductscience.org/library/papers/9811686PubMed
9223521Psi- vectors: murine leukemia virus-based self-inactivating and self-activating retroviral vectors.J Virol1997https://conductscience.org/library/papers/9223521PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8527482

GET https://conductscience.org/api/papers/v1/8527482/authors